Carlos Parra-Herran
Brigham and Women's Hospital
142 Papers
288 Citations
Carlos Parra-Herran is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 19, co-authored 89 publications. Previous affiliations of Carlos Parra-Herran include Jackson Memorial Hospital & University of Ottawa.
Chat about Author
Papers
Pilot Study on the Utility of Circulating HER2/Neu Levels in the Serum of Breast Cancer Patients.
Sarah Morgan,Sarah Morgan,Yutaka Amemiya,Yutaka Amemiya,Elzbieta Slodkowska,Elzbieta Slodkowska,Fang-I Lu,Fang-I Lu,Carlos Parra-Herran,Carlos Parra-Herran,Sharon Nofech-Mozes,Sharon Nofech-Mozes,Maureen E. Trudeau,Ekaterina Olkhov-Mitsel,Arun Seth,Arun Seth,Wedad Hanna,Wedad Hanna +17 more
TL;DR: Findings suggest that post initial tissue diagnosis (tHER2), sHER2 assay may supplement subsequent tissue tests to monitor disease status and response to therapy, and further studies to assess the role of HER2 targeted therapies in sHER-positive/t HER2-negative cases upon disease progression are warranted.
2
Gynecologic Pathology Journal Club: A 2-year, Worldwide Virtual Learning Experience With a Focus on Mentorship and Inclusion.
Natalie Banet,Carlos Parra-Herran,Joseph Rabban,Esther Oliva,Lora H Ellenson,Kay J Park,Naveena Singh,Kyle Devins,Sameera Rashid,Karen L. Talia +9 more
TL;DR: A 2-year virtual gynecologic pathology journal club provided mentorship and inclusivity to 59 global presenters and 16,138 viewers, promoting evidence-based medicine and critical evaluation skills among trainees and early-career pathologists worldwide.
2
Does timing of intraperitoneal chemotherapy initiation following primary cytoreductive surgery with bowel resection impact outcomes in patients with advanced ovarian cancer
TL;DR: Administration of IP chemotherapy in the first post-operative cycle after bowel resection is not associated with increased post-operative complications in women with advanced ovarian carcinoma undergoing primary cytoreductive surgery.
2